SGLT-2 Inhibitors Cut Risk Of Death In Diabetics, Data Shows | Latest News RSS feed

SGLT-2 Inhibitors Cut Risk Of Death In Diabetics, Data Shows - Latest News


SGLT-2 inhibitors cut risk of death in diabetics, data shows

AstraZeneca has unveiled findings of a new analysis of data from the CVD-REAL study, showing a significant cut in the risk of all-cause death (ACD) in patients with type II diabetes taking SGLT-2 inhibitors. The real-world evidence study is evaluating the ... read more

Real-world study shows type 2 diabetics treated with SGLT-2 inhibitors experienced less risk of hospitalization for heart failure and death

The data showed that treatment with SGLT-2 inhibitors ... and death from any cause by 51% (hazard ratio = 0.49; p<0.001). For the composite endpoint of hospitalization for heart failure and all-cause mortality, the reduction in risk was 46% (hazard ... read more

Newer type 2 diabetes drugs show heart protective quality in study

WASHINGTON (Reuters) - A newer class of type 2 diabetes drugs significantly cut the risk of death and ... according to data released on Sunday from a so-called real world study sponsored by AstraZeneca. The drugs, known as SGLT-2 inhibitors, work by ... read more

Looking for another news?


A new drug cut 32% of deaths in heart-risk patients, and it could revolutionize the way we treat type 2 diabetes

So reducing cardiovascular risk ... diabetes drug to show heart-protective results in a large cardiovascular trial. But they did not unveil detailed data until Thursday at a medical meeting in Stockholm. In calculating the combined number of cardiac deaths ... read more


Newer type 2 diabetes drugs show heart protective quality in study

WASHINGTON, March 19 (Reuters) - A newer class of type 2 diabetes drugs significantly cut the risk of death ... according to data released on Sunday from a so-called real world study sponsored by AstraZeneca. The drugs, known as SGLT-2 inhibitors, work ... read more

Newer type 2 diabetes drugs show heart protective quality: study

The drugs, known as SGLT-2 inhibitors ... diabetes. (Representational Image) A newer class of type 2 diabetes drugs significantly cut the risk of death and hospitalization for heart failure compared with other medicines for the disease, according to data ... read more

Newer type 2 diabetes drugs show heart protective quality in study

WASHINGTON (Reuters) - A newer class of type 2 diabetes drugs significantly cut the risk of death and ... according to data released on Sunday from a so-called real world study sponsored by AstraZeneca. The drugs, known as SGLT-2 inhibitors, work by ... read more

Newer type 2 diabetes drugs show heart protective quality in study

WASHINGTON, March 19 (Reuters) - A newer class of type 2 diabetes drugs significantly cut the risk of death ... to data released on Sunday from a so-called real world study sponsored by AstraZeneca (NYSE: AZN - news) . The drugs, known as SGLT-2 inhibitors ... read more

Newer type 2 diabetes drugs show heart protective quality in study

WASHINGTON (Reuters) - A newer class of type 2 diabetes drugs significantly cut the risk of death and ... according to data released on Sunday from a so-called real world study sponsored by AstraZeneca. The drugs, known as SGLT-2 inhibitors, work by ... read more

Newer type 2 diabetes drugs show heart protective quality in study

WASHINGTON (Reuters) - A newer class of type 2 diabetes drugs significantly cut the risk of death and ... according to data released on Sunday from a so-called real world study sponsored by AstraZeneca. The drugs, known as SGLT-2 inhibitors, work by ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us